Search alternatives:
points decrease » point increase (Expand Search)
point decrease » point increase (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
30 point » 3d point (Expand Search), 50 points (Expand Search), _ point (Expand Search)
3 points » _ points (Expand Search), _ point (Expand Search), 5 point (Expand Search)
points decrease » point increase (Expand Search)
point decrease » point increase (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
30 point » 3d point (Expand Search), 50 points (Expand Search), _ point (Expand Search)
3 points » _ points (Expand Search), _ point (Expand Search), 5 point (Expand Search)
-
1
-
2
-
3
PI+ CD3+ T cells decrease at day 14 after IR while PI+ CD3- cells decrease at all time points.
Published 2024Subjects: -
4
Decreased cell stiffness after dissociation of intercellular adhesion.
Published 2014“…At each interval, we obtained (<b>A</b>) microscopic images (original magnification: 100x), (<b>B</b>) AFM topography images (scan size <b>B1</b>, 50 µm; <b>B2</b>, 20 µm; <b>B3</b>, 33.3 µm), and (<b>C</b>) height measurements at the cross section of an individual cell. …”
-
5
Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro.
Published 2009“…<p>(A) In order to avoid overlap of the heavy chain signal (∼50 kDa) with the βIII-tubulin signal (∼55 kDa) in the immunoprecipitation using the Capzb2 monoclonal antibody (mAb), the antibody was coupled to the protein G/A beads through cross-linking. βIII-tubulin and Capzb2 signals were each detected following immunoprecipitation from brain lysate with both βIII-tubulin rabbit antibody (rAb)-coupled beads and Capzb2 mAb-coupled beads. …”
-
6
-
7
-
8
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…<p>(A) RFF is decreased by alterations in heart rate. …”
-
9
-
10
-
11
Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR.
Published 2024Subjects: -
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20